澳大利亚Panbio Limited   
澳大利亚Panbio公司在临床实验室应用的创新性的检测产品开发方面一直保持全球领先的良好记录。Panbio一直在登革热（Dengue fever）、罗斯河热（Ross river fever）的诊断试剂产品方面保持着全球第一的市场地位。公司的西尼罗河脑炎（West Nile encephalopalitis）诊断试剂在全球首家获得美国FDA注册。Panbio登革产品拥有全球最广的产品系列，有着全球最广的应用。
2008年Inverness Medical 收购Panbio Limited
    



Since 2001, Inverness Medical has been focused on the development, manufacture and marketing of advanced consumer and professional medical diagnostic products. Through strategic acquisitions and the effective use of a vast intellectual property portfolio, the company now operates on a global scale providing locally relevant, world-class diagnostic tests and services to customers in the private, public and non-government organizational (NGO) sectors.

Inverness Medical concentrates its efforts in five key areas: infectious diseases, cardiology, women’s health, drugs of abuse and oncology. The organisation owns numerous patented technologies for both consumer and professional diagnostics, and offers an expanding range of products that includes brands such as Clearview®, Testpack®, Binax®, Determine® and Biosite®.

Inverness Medical is led by an experienced and committed executive team dedicated to bringing to market new and innovative products through breakthrough research and development. Strategic acquisitions are particularly meaningful to the business, enabling it to expand and diversify its range of offerings.

Through acquisitions Inverness Medical has become one of the largest patient health management providers in the world. We enable and empower patients and their families to take charge of their own health.

In January 2008, Inverness Medical acquired Panbio Limited - a leading developer of tests used in the diagnosis of flaviviruses and other arthropod-borne viruses. Panbio was first-to-market with diagnostics for Ross River fever, west Nile encephalitis and dengue fever and its range of technical platforms includes enzymelinked immmunosorbant assay (ELISA) and rapid lateral flow technology. Panbio® now lives on as a premium Australian brand of diagnostic products within the global Inverness Medical portfolio. The Panbio® range of dengue diagnostics lead the world in dengue detection.

Today, Inverness Medical is the world’s sixth largest, and fastest growing, global in vitro diagnostics company. The organisation has major research and development and manufacturing facilities in North America, Europe, the Middle East and Asia Pacific and global sales and distribution capabilities are also undergoing rapid expansion.

With its global footprint and time-tested brands Inverness Medical continues to maintain focus on locally relevant disease areas ensuring that our customers have the tools for the diagnosis and management of diseases and conditions.